EdgarLookup

Aprea Therapeutics, Inc. — 3 Filings

28 3 filings on record

This page lists all 3 filings submitted to the SEC by Aprea Therapeutics, Inc. (APRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aprea Therapeutics, Inc. has filed 28 3 documents with the SEC since 2019. To view all SEC filings by Aprea Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 4 424B3 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP PRE 14A S-1 S-1/A S-1MEF S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
3 OWNERSHIP DOCUMENT 0001104659-24-056395 May 2, 2024 May 1, 2024
3 OWNERSHIP DOCUMENT 0001104659-23-095013 Aug 24, 2023 Aug 23, 2023
3 OWNERSHIP DOCUMENT 0001104659-23-057258 May 8, 2023 May 5, 2023
3 OWNERSHIP DOCUMENT 0001104659-23-008059 Jan 30, 2023
3 FORM 3 0001140361-22-020785 May 26, 2022 May 16, 2022
3 FORM 3 0001140361-22-020783 May 26, 2022 May 16, 2022
3 FORM 3 0001140361-22-020781 May 26, 2022 May 16, 2022
3 FORM 3 0001140361-22-020779 May 26, 2022 May 16, 2022
3 0000905148-20-001048 Sep 29, 2020 Sep 28, 2020
3 0000905148-20-001029 Sep 18, 2020 Sep 16, 2020
3 0000905148-20-000731 Jun 29, 2020 Jun 26, 2020
3 0000905148-20-000730 Jun 29, 2020 Jun 26, 2020
3 PRIMARY DOCUMENT 0001123292-19-001194 Oct 2, 2019
3 3 0001104659-19-052741 Oct 2, 2019
3 FORM 3 SUBMISSION 0000899243-19-024764 Oct 2, 2019
3 OWNERSHIP DOCUMENT 0001144204-19-047034 Oct 2, 2019
3 FORM 3 0001140361-19-017864 Oct 2, 2019
3 FORM 3 0001140361-19-017862 Oct 2, 2019
3 FORM 3 0001140361-19-017861 Oct 2, 2019
3 FORM 3 0001140361-19-017859 Oct 2, 2019
3 FORM 3 0001140361-19-017856 Oct 2, 2019
3 FORM 3 0001140361-19-017854 Oct 2, 2019
3 FORM 3 0001140361-19-017852 Oct 2, 2019
3 FORM 3 0001140361-19-017850 Oct 2, 2019
3 FORM 3 0001140361-19-017849 Oct 2, 2019
3 FORM 3 0001140361-19-017846 Oct 2, 2019
3 FORM 3 0001140361-19-017845 Oct 2, 2019
3 FORM 3 0001140361-19-017843 Oct 2, 2019